---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007268"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T01:58:26.016246+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# LIXTE appoints Sidney Braun CEO of Liora; GBP 50K signing bonus, GBP 25K monthly retainer

## Summary
- Braun becomes CEO of Liora Technologies Europe Ltd., effective Feb 13, 2026.
- Signing bonus of GBP 50,000 plus monthly retainer of GBP 25,000 (both excl. VAT).
- If Liora is sold, Braun gets 20% of net purchase price via Allocation Deed.
- Braun helped create Liora and facilitated LIXTE's acquisition of Liora's assets in Nov 2025.
- He brings 20+ years healthcare experience; previously built Remicade infusion network.

## SEC filing metadata
- accession: 0001493152-26-007268
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315226007268/0001493152-26-007268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315226007268/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007268
- JSON: https://secwatch.observer/filing/0001493152-26-007268.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007268.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.